ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing and gene insertion to develop new medicines.

To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines. 

ReNAgade Therapeutics – RNA Without Limits

F2 Ventures

MPM Capital

ReNAgade Therapeutics

At #JPM2024 next week, ReNAgade CEO Amit Munshi will present on the exciting updates we are making across our broad portfolio of novel RNA medicines. More details: https://bit.ly/48IpqJs

Our CEO, Amit Munshi, recently spoke with In Vivo reporter Melanie Senior, and told the publication that RNA medicines are among “the next set of modalities that will change what medicines look like.” Read the full story here: https://bit.ly/3RMqC8N

Welcome Paul Perreault to ReNAgade’s Board of Directors! With over 40 years of leadership experience across the biotechnology industry, Mr. Perreault will be invaluable as we continue to build our portfolio of novel RNA medicines. Read more: https://bit.ly/3t3Sz2u

Here is what the team at ReNAgade values about our cutting-edge science.

https://renagadetx.com/

#science #culture #biotech

RNA medicine and an inclusive culture are just a few of the reasons you should consider joining our team. Don't take our word for it, hear what Pooja and Johnny have to say about ReNAgade.

https://ow.ly/x3Tx50Q81MY

#careers #science #biotech

Dunk tanks, refreshing people, and all-team problem-solving are just a few of the reasons Reggie, Kimberly, and James are happy with the ReNAgade #experience.

https://renagadetx.com/

#biotech #experience #dunktank

We’re honored to have been nominated by The New England Venture Capital Association as Emerging Life Science Company of the Year at the #NEVYs23. We’re excited for the recognition and look forward to celebrating with the rest of the nominees!

Gain insights from Trevor, our Gene-Editing Co-op, as he shares about his experience at ReNAgade this semester. #intern #careers #biotech

At #mRNA2023, ReNAgade will present preclinical data demonstrating novel and proprietary lipid nanoparticle (LNP)-based delivery of mRNA to extra-hepatic tissue in a plenary session on 11/1 at 3:18PM CET (10:18AM ET). Full press release: https://bit.ly/3QByFVw

Taylor in Delivery Chemistry shared his favorite part about the #culture at ReNAgade…we’ll give you a hint: 🎶 🎸 🎙️

ReNAgade Therapeutics is a company specializing in RNA delivery systems for addressing various diseases.

Berzack Advisors is a consulting firm with a wide range of active competitors, including Gallagher and Cognizant.

Berzack Advisors

Coastal is one of the top alternatives to IT Consulting, offering a range of IT services.

Coastal

Renagade TX is a technology solutions provider that specializes in custom software development, IT consulting, and digital transformation services. The company prides itself on its innovative approach to solving complex business challenges through cutting-edge technology.

Associate Director of IP

Senior Patent Counsel

Patent Agent

Postdoctoral Researcher

Consulting Chemist

Research Assistant

Associate Director of IP at Stealth Stage Startup

Michael Manas

Chief Executive Officer & President

Chairman

Chairman, Board of Directors

Member Board Of Directors

Co-Founder

Chief Executive Officer & President at ReNAgade Therapeutics

Amit Munshi

Director | Program Lead

Director, Translational Sciences, Research

Associate Director, Research

Senior Scientist, Severe Genetic Disease Research

Scientist II, Stem Cell Biology

Scientist I, Stem Cell Biology

Postdoctoral Fellow

Research Leader | Gene and Cell Therapy

Megan Hoban

Associate Director, Scientific & Medical Affairs

US Medical Publications Lead- Type 1 Diabetes

Senior Manager, Medical Affairs

Manager, Medical Affairs

Scientist, Research Department

Immunology Research Fellow

Doctoral Researcher, Immunology Group

Research Technician

Jacquelyn Brown

Associate Director

Graduate Student

Undergraduate Researcher

Jacob Layer

Associate Director, Procurement

Global Category Manager (Associate Director) - Cell Therapy Process Development

Director, Strategic Sourcing - Gene Therapy Program

Associate Director: Procurement, Compliance, Safety and Operations -Gene Therapy Program-

Laboratory Service Assistant D, On-assigment through Aerotek

Microbiologist

Frank Shipley

Associate Director, DMPK

Research Senior Scientist

Research Scientist II, DMPK

Associate Scientist

Associate Pharmacokineticist, Clinical Pharmacology

Lead Associate

Research Associate II

Research Associate I

Research Scientist I, Dr. Stanley Mcknight's lab

Assistant Research Scientist, Dr. Stanley McKnight's lab

Sara Shum

Associate Director | Gene editing

Principal Scientist

Senior Scientist

Senior Scientist I

Scientist II

Consultant

Research Associate

Intern

Dan Egan

Chief Scientific Officer

Chief Early Development Officer

Senior Vice President

Senior Vice President R&D Non Clinical

consultant

CSO ReNAgade

Peter Smith

Principal Software Engineer

Senior Software Developer

Software Engineer

Reggie Pawle

Head of Bioanalysis

Associate Director, Bioanalytical and Biomarker, DMPK

Principal Scientist, Biomarker & DMPK

Investigator, Preclinical Profiling

Senior Scientist, Metabonomics

Senior Scientist, Analyitcal & ADME

Dong Wei

Associate Director of MolPath

Research Investigator

Senior Research Technician

Research Technician in Guinan Laboratory

Laboratory Technician

Data Analyst

Associate Director of MolPath at ReNAgade Therapeutics

Matthew Theisen

Scientist

Research Fellow

Associate Director at ReNAgade Therapeutics

Te-Chen Tzeng

Sr. Director

Site Head / Ex. Director Simnova Biotherapeutics

Global Project Head / Sr. Principal Scientist

Lab Head / Principal Scientist

Staff Scientist / Team Lead

Instructor in Medicine / Assistant in Biology

Graduate Research Assistant

RNA Medicine, Immunology, IO & Cell Therapy Discovery

Yinghua Wang

Senior Director, Corporate Development

Director, Corporate Business Development

Director, Business Development & Strategic Alliances

Associate Director, Corporate Development

Associate Director, Business Development

Scientific Advisor

Project Analyst

Business Plan Developer

Project Manager

Assistant Lacrosse Coach

Lab Technician

Corporate Development at ReNAgade Therapeutics

Alex Lagadinos

Scientist II. Head of In Vivo Pharmacology

Principal Research Associate

Senior Research Associate

Scientist I

Scientist II at ReNAgade Therapeutics

Tequana Bayless

Chief Business Officer

Senior Vice President, Corporate Development

Vice President, Business Development

Head, Innovation and Alliances

Executive Director, Healthcare Investment Banking

Lieutenant and Executive Officer, Naval Criminal Investigative Service

Lieutenant Junior Grade, Contracting Officer

Chief Business Officer, ReNAgade Therapeutics

Brian Shuster

CSO-Editing

VP Gene editing and Discovery

VP Technology

Associate Director, Protein Engineering and Computational Biology

Senior Scientist, Computational Biology

Senior Scientist, Biochemistry and Structural Biology

Senior Scientist II, Biochemistry and Structural Biology

CSO-Editing ReNAgade therapeutics

Hari Jayaram

Director, Operations & Administration

Senior Manager, Operations

Executive Assistant to CEO

Executive Assistant To Chief Executive Officer

Executive Assistant/Office Manager

Director, Operations & Administration at ReNAgade Therapeutics

Kathleen Moeckel

Associate Director-Delivery Chemistry

Scientist-II

Postdoctoral Research Associate

Senior Research Scientist

Exchange visitor/Intern-HIV DPU

Oligonucleotide synthesis, Lipid discovery, LNP optimization, Bioconjugation

Ganapathy Sankaran

Senior Director Portfolio and Alliance Management

CMC Program Lead Director - Clinical Portfolio Operations

Senior Manager, CMC Project Management

Alliance & Business Development Manager

Principal & Founder

Biotech Portfolio and Alliances Leader

Jeremy Webber

Chief Financial Officer

Board Member

Executive Vice President and Chief Financial Officer

Chief Financial Officer at ReNAgade Therapeutics

Laurie Stelzer

Head of Platform

Senior Director RNA Sciences

Director RNA Sciences and Delivery

Associate Director, Molecular & RNA Sciences

Senior Scientist, Delivery Sciences

Senior Scientist,  Analytical Development

Instructor / Research Specialist II

Instructor / Postdoctoral Research Associate

Head of Platform at ReNAgade Therapeutics

Inna Shcherbakova

Head of Formulation

Group Lead

Research Scientist III

Jie Su

Director of Information Technology

Director/Head of IT

Irving Allen

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	May 7, 2024 8:33 PM	e20cdd46
public peers	general	May 7, 2024 8:33 PM	3d83f96b
news daily refresh	general	Jul 25, 2024 12:00 PM	ea352eab
news processing daily refresh	general	May 21, 2024 2:49 AM	af9ae144
news impact assignment daily	general
news processing basic	general	May 7, 2024 8:33 PM	e12a69d5
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general
news basic	general	May 7, 2024 8:33 PM	a054dacf
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
swot analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
customer profile	customers

COM:RENAGADETX

Renagade TX